search
Back to results

Chronic Electrical Stimulation to Reduce Bladder Hyperreflexia

Primary Purpose

Neurogenic Bladder Dysfunction

Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Genital Nerve Stimulation
Sponsored by
VA Office of Research and Development
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Neurogenic Bladder Dysfunction focused on measuring Neurogenic bladder dysfunction, Genital Nerve Stimulation, Electrical Stimulation, Urinary Incontinence, Spinal cord injury

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Suprasacral neurogenic bladder following spinal cord injury, stroke, or multiple sclerosis
  • Neurologically stable
  • Skeletally mature, over 18 years of age.
  • Reflex bladder contractions confirmed by cystometrogram
  • At least six (6) months post spinal cord injury, stroke, or multiple sclerosis diagnosis
  • Able to understand and comply with study requirements
  • Able to understand and give informed consent

Exclusion Criteria:

  • Active sepsis
  • Open pressure sores on penis
  • Significant trauma, erosion or stricture of the urethra
  • Pregnancy
  • Individuals who do not speak English.

Sites / Locations

  • Syracuse VA Medical Center, Syracuse, NY
  • Louis Stokes VA Medical Center, Cleveland, OH

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

Genital Nerve Stimulation

Arm Description

Study participants in this arm will use take-home genital nerve stimulation for 24+ months in order to assess its effectiveness at decreasing urinary incontinence. In order to set effective genital nerve stimulation parameters, study participants will undergo clinical urodynamics every 6 months in which sensitivity to and tolerance of electrical stimulation are assessed.

Outcomes

Primary Outcome Measures

Incontinence
The investigators will collect a record of leakage episodes (metric for incontinence) from the specified period.

Secondary Outcome Measures

Bladder Capacity
The investigators will measure bladder capacity in mL during acute urodynamics trials

Full Information

First Posted
March 5, 2018
Last Updated
October 24, 2023
Sponsor
VA Office of Research and Development
Collaborators
Syracuse VA Medical Center
search

1. Study Identification

Unique Protocol Identification Number
NCT03472599
Brief Title
Chronic Electrical Stimulation to Reduce Bladder Hyperreflexia
Official Title
Long Term Genital Nerve Stimulation to Improve Urinary Continence
Study Type
Interventional

2. Study Status

Record Verification Date
October 2023
Overall Recruitment Status
Completed
Study Start Date
November 1, 2019 (Actual)
Primary Completion Date
September 30, 2023 (Actual)
Study Completion Date
September 30, 2023 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
VA Office of Research and Development
Collaborators
Syracuse VA Medical Center

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Product Manufactured in and Exported from the U.S.
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
Bladder spasms after spinal cord injury (SCI) can result in incontinence, urinary tract infections, kidney damage, trigger dangerous increases in blood pressure and decrease independence and quality of life. The investigators' long-term goal is to develop and provide a "bladder pacemaker" able to restore bladder continence for Veterans with SCI. Electrical stimulation of sensory nerves can stop bladder spasms during a doctor visit. However, this approach has not been tested during long term home use. This proposal will 1) determine how well sensory stimulation reduces incontinence and improves quality of life for Veterans with SCI during 1 year of home use, and 2) produce an effective take home system that can be used by more Veterans and other VAs.
Detailed Description
The clinical problem of neurogenic detrusor overactivity (bladder hyper-reflexia) is among the most serious problems encountered by Veterans with neurologic injuries such as spinal cord injury (SCI). The majority of persons with SCI suffer from neurogenic bladder (73%) and only 17% of persons with traumatic SCI manage their bladders with voluntary micturition. The investigators' long-term goal is to develop and clinically implement a "bladder pacemaker" able to restore bladder continence for Veterans with spinal cord injury (SCI). This proposal will 1) determine the long-term effectiveness of genital nerve stimulation (GNS) to chronically ( 1 year) reduce urinary incontinence and improve quality of life for Veterans with SCI, and 2) develop and produce an effective take home GNS system that can be used by more Veterans, given to Veterans at the end of the study and used in future multi-VA studies. The rationale for studying chronic GNS is based on the demonstration in humans with SCI that abnormal hyper-reflexive bladder contractions can be acutely inhibited and bladder capacity acutely increased using GNS. The peripheral and easily accessible location of the dorsal genital nerve (DGN) allows surface stimulation and therefore provides the potential for a less complicated surgical intervention than is currently available, increasing the number of individuals who could benefit from bladder control neural prostheses. While GNS has been demonstrated to be effective acutely by multiple groups, relatively few groups have attempted to test this approach for more than a day.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Neurogenic Bladder Dysfunction
Keywords
Neurogenic bladder dysfunction, Genital Nerve Stimulation, Electrical Stimulation, Urinary Incontinence, Spinal cord injury

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Model Description
All subjects will take home skin surface electrodes and a simple one-channel electrical stimulators appropriate for extended use set to the stimulus parameters found effective during an initial urodynamics test. Genital nerve stimulation will be applied either continuously or on-demand when individuals turn stimulation on when they feel the onset of bladder leaking.
Masking
None (Open Label)
Allocation
N/A
Enrollment
17 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Genital Nerve Stimulation
Arm Type
Experimental
Arm Description
Study participants in this arm will use take-home genital nerve stimulation for 24+ months in order to assess its effectiveness at decreasing urinary incontinence. In order to set effective genital nerve stimulation parameters, study participants will undergo clinical urodynamics every 6 months in which sensitivity to and tolerance of electrical stimulation are assessed.
Intervention Type
Other
Intervention Name(s)
Genital Nerve Stimulation
Intervention Description
Genital nerve stimulation activates sensory afferents that travel through the pudendal nerves and enters the spinal cord through the sacral dorsal root ganglia. Inhibitory spinal reflex pathways are activated, causing increased sympathetic outflow through the inferior mesenteric ganglion and hypogastric nerve and also decreased parasympathetic efferent drive through the pelvic nerve, resulting in inhibited bladder contractions.
Primary Outcome Measure Information:
Title
Incontinence
Description
The investigators will collect a record of leakage episodes (metric for incontinence) from the specified period.
Time Frame
Collected over 24 months
Secondary Outcome Measure Information:
Title
Bladder Capacity
Description
The investigators will measure bladder capacity in mL during acute urodynamics trials
Time Frame
Collected over 24 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Suprasacral neurogenic bladder following spinal cord injury, stroke, or multiple sclerosis Neurologically stable Skeletally mature, over 18 years of age. Reflex bladder contractions confirmed by cystometrogram At least six (6) months post spinal cord injury, stroke, or multiple sclerosis diagnosis Able to understand and comply with study requirements Able to understand and give informed consent Exclusion Criteria: Active sepsis Open pressure sores on penis Significant trauma, erosion or stricture of the urethra Pregnancy Individuals who do not speak English.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Kenneth J. Gustafson, PhD
Organizational Affiliation
Louis Stokes VA Medical Center, Cleveland, OH
Official's Role
Principal Investigator
Facility Information:
Facility Name
Syracuse VA Medical Center, Syracuse, NY
City
Syracuse
State/Province
New York
ZIP/Postal Code
13210
Country
United States
Facility Name
Louis Stokes VA Medical Center, Cleveland, OH
City
Cleveland
State/Province
Ohio
ZIP/Postal Code
44106-1702
Country
United States

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
28198657
Citation
Bourbeau DJ, Creasey GH, Sidik S, Brose SW, Gustafson KJ. Genital nerve stimulation increases bladder capacity after SCI: A meta-analysis. J Spinal Cord Med. 2018 Jul;41(4):426-434. doi: 10.1080/10790268.2017.1281372. Epub 2017 Feb 15.
Results Reference
background
PubMed Identifier
29334338
Citation
Bourbeau DJ, Gustafson KJ, Brose SW. At-home genital nerve stimulation for individuals with SCI and neurogenic detrusor overactivity: A pilot feasibility study. J Spinal Cord Med. 2019 May;42(3):360-370. doi: 10.1080/10790268.2017.1422881. Epub 2018 Jan 15.
Results Reference
result

Learn more about this trial

Chronic Electrical Stimulation to Reduce Bladder Hyperreflexia

We'll reach out to this number within 24 hrs